New York City-based Memorial Sloan Kettering Cancer Center entered into a multiyear partnership with healthcare analytics startup Cota, the company announced Nov. 9.
Memorial Sloan Kettering will provide the startup with anonymized clinical data, which Cota will organize through its Cota Nodal Address system. The Cota Nodal Address categorizes clinical and genomic data based on demographics, diseases and intended therapies of similar patients.
The data-sharing effort will help Memorial Sloan Kettering clinicians personalize patient care and advance oncology research, while also expanding Cota's evidence database.
"This organized and analyzed data will help our physicians practice more efficiently, optimizing the care a patient receives based on a variety of characteristics and ultimately can improve outcomes for all cancer patients as this knowledge is shared," said Paul Sabbatini, MD, deputy physician-in-chief for clinical research at Memorial Sloan Kettering.